A Randomized, Double-blind, Placebo-controlled Trial to Investigate the Efficacy and Safety of Cannabidiol (CBD; GWP42003-P) in Infants With Infantile Spasms Following an Initial Open-label Pilot Study
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 20 Jul 2018
At a glance
- Drugs Cannabidiol (Primary)
- Indications Infantile spasms
- Focus Adverse reactions
- Sponsors GW Pharmaceuticals
- 13 Jul 2018 Status changed from recruiting to active, no longer recruiting.
- 20 Oct 2017 Planned End Date changed from 1 Jan 2020 to 1 Dec 2018.
- 20 Oct 2017 Planned primary completion date changed from 1 Dec 2019 to 1 Dec 2018.